SCOTUS could strike an 'uneasy compromise' for Myriad
This article was originally published in Clinica
Executive Summary
As the US Supreme Court on 15 April wrestled with whether patents involving human genes are needed to incentivize investment in R&D or if claims lock up inventions and prevent research and new uses, the justices turned to analogies using baseball bats, Amazon trees and even the ingredients of baking a chocolate chip cookie to help them flesh out the debate.